chr6-31672137-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_021221.3(LY6G5B):āc.461A>Gā(p.Glu154Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,613,012 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_021221.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LY6G5B | NM_021221.3 | c.461A>G | p.Glu154Gly | missense_variant | 3/3 | ENST00000375864.5 | NP_067044.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LY6G5B | ENST00000375864.5 | c.461A>G | p.Glu154Gly | missense_variant | 3/3 | 1 | NM_021221.3 | ENSP00000365024 | P1 | |
LY6G5B | ENST00000409525.1 | c.296A>G | p.Glu99Gly | missense_variant | 2/2 | 1 | ENSP00000386365 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152076Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000324 AC: 8AN: 246640Hom.: 0 AF XY: 0.0000372 AC XY: 5AN XY: 134420
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1460818Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 726722
GnomAD4 genome AF: 0.000158 AC: 24AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74416
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2021 | The c.461A>G (p.E154G) alteration is located in exon 3 (coding exon 3) of the LY6G5B gene. This alteration results from a A to G substitution at nucleotide position 461, causing the glutamic acid (E) at amino acid position 154 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at